MLTX: MoonLake Pharma Kompaniya qiymatining sof foydaga nisbati

MoonLake Immunotherapeutics AG (MLTX) brendining ramzi va logotipi

Ishonchli komponentlar logistikasi testlar barqarorligini ta'minlab, psoriazga qarshi innovatsion nanotantilar yaratilishini osonlashtiradi. MoonLake Immunotherapeutics (MLTX) kompaniyasining bazaviy P/E ko'rsatkichi ushbu tendentsiyani aks ettiradi, bunda joriy marka -3.90 ga tengdir. Biroq, klinik sinovlarning muvaffaqiyatsizligi xavfi kapitalni yo'q qilishi mumkin, bu esa ushbu biznes modelining hayotiylik tahlilini yakunlaydi.

P/E multiplikatori: MoonLake Pharma (MLTX) 28.04.2023 - 16.11.2026 uchun

MoonLake Corp (MLTX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning jamlanma tahlili:MoonLake Immunotherapeutics AG
MoonLake Pharma tayyor mahsulotlari

MoonLake Immunotherapeutics (MLTX) uchun P/E koeffitsiyenti tendentsiyasi bozor kapitalizatsiyasi va sof foyda o'rtasidagi bog'liqlikni aks ettirib, -3.90 joriy qiymatiga yetdi. Ushbu ko'rsatkich bir dollar foydaning tannarxini o'lchaydi, bu esa investorlarga klinik sinovlar yakunlanganidan keyin innovatsion yallig'lanish kasalliklarini davolashga bo'lgan kelajakdagi talabning joriy narxga qanchalik kiritilganini baholash imkonini beradi.

Raqobatdosh kompaniyalar tahlili

P/E multiplikatori Ascendis Pharma Inc.|Narx-foyda koeffitsiyenti MDGL (Madrigal Pharma)|CORT (Corcept Therapeutics Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati rhythmtx.com RYTM|AKRO - Narx-foyda koeffitsiyenti|Metsera Therapeutics - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Crinetics Pharma|NAMS (NewAmsterdam Pharma Company N.V.) - Narx-foyda koeffitsiyenti|SLNO: Bozor narxining sof foydaga nisbati|FOLD (Amicus Corp) - P/E multiplikatori|P/E multiplikatori 89bio, Inc.|P/E multiplikatori AGIO|Narxning foydaga nisbati GPCR (Structure Therapeutics Inc)|Narxning foydaga nisbati mimedx.com MDXG|Rezolute Bio (RZLT) - Kapitalizatsiyaning foydaga nisbati|LXRX - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati mbxbio.com MBX|Altimmune Inc (ALT) - Narxning foydaga nisbati|AARD - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Sagimet Biosciences Inc|BioAge Labs, Inc (BIOA) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati biomeafusion.com (BMEA)|Narx-foyda koeffitsiyenti Quince Therapeutics Inc QNCX|P/E multiplikatori GUTS (Fractyl Health, Inc.)|vtvtherapeutics.com - Narxning foydaga nisbati|agapeatpgroup.com - P/E multiplikatori|PLUR: Narxning foydaga nisbati|Synlogic, Inc. (SYBX) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati LPCN (lipocine.com)|MTNB (Matinas BioPharma Holdings) - P/E multiplikatori|P/E multiplikatori Spruce Biosciences, Inc.|P/E multiplikatori GLTO|CTCX - Kapitalizatsiyaning foydaga nisbati|Lumos Pharma, Inc. - Narx-foyda koeffitsiyenti|Organovo (ONVO) - Kapitalizatsiyaning foydaga nisbati|RDUS: Narx-foyda koeffitsiyenti